Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The New Dual Activation Pain Relief Cream

SURVEY RESULTS: Medical Marijuana

High serum omega-6 polyunsaturated fatty acid concentrations linked to lower risk of type 2 diabetes

Recipe: Mega-Golden Milk

Vitamin D supplementation shows promise for Hashimoto's thyroiditis

Sweep Away Senile Cells

A Paleolithic-type diet may help reduce future risk of diabetes and cardiovascular disease

Large whey protein breakfast may help manage type 2 diabetes

Decreased levels of vitamin D associated with reduced methylation in African American teens

Selenium — What Is it and Where Do I Get It?

 
Print Page
Email Article

Pain Drug Can Cancel Out Low-Dose Aspirin’s Anti-Clotting Action

  [ 43 votes ]   [ Discuss This Article ]
www.ProHealth.com • December 15, 2009


Aspirin’s blood thinning effect was thought to counteract Celebrex’s clot-promoting potential - but the reverse may occur with low doses.

Millions of Americans take Celebrex (generic name celecoxib) for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests.

In laboratory studies, University of Michigan researchers found that several coxibs, the drug class to which Celebrex belongs,(1) interfere with aspirin’s ability to discourage blood clots, if the aspirin is taken in low doses. In animal studies, the researchers found more clumping of platelets – the initial stage of clotting – in blood from animals given Celebrex and low-dose aspirin than in animals given only low-dose aspirin.

The report appears in the Dec 1 issue of the Proceedings of the National Academy of Sciences.(2)

Low-dose aspirin may be recommended for several reasons:

• Doctors frequently advise daily low-dose aspirin (81 mg) for patients who have heart conditions, notably a serious form of angina known as unstable angina, or for patients who are at risk of second heart attacks. Aspirin is well-known for its ability to discourage formation of blood clots that can lead to heart attack and stroke.

• In addition, arthritis patients who take Celebrex regularly are often put on low-dose aspirin because this is thought to counteract Celebrex’s own potential clot-promoting effect.

“There are many people who take low-dose aspirin, perhaps as many as half of men over 50. If they are also prescribed Celebrex for arthritis or other pain, our results suggest that the Celebrex will probably interfere with the aspirin’s action,” says William L. Smith, PhD,  the study’s senior author and chair of the biochemistry department at University of Michigan Medical School.

“The greatest risk is having people take Celebrex who are taking aspirin for cardiovascular problems that are known to be mitigated by aspirin, including patients with unstable angina or those at risk for a second heart attack,” he says. In unstable angina, small clots form in arteries and interfere with blood flow.

Previous studies of healthy subjects found no ill effect on blood clotting when Celebrex was combined with aspirin at higher doses, specifically a daily “regular” aspirin tablet (324 mg), Smith notes.

• So it may be that a higher aspirin dose, or spreading out the time between taking low-dose aspirin and Celebrex, will allow aspirin to be effective.

• However, aspirin’s undesirable effects on the gastrointestinal tract at higher doses when taken long-term would have to be taken into account.

First, though, the effect seen in the U-M study needs to be replicated in human studies, perhaps in older patients who have conditions such as rheumatoid arthritis, says Smith. If the effect holds true in people, it will be important to determine if a balance in dose and/or dose regimens can be found so that aspirin and Celebrex can both be effective.

Funding: National Institutes of Health, Heart and Stroke Foundation of Canada

References
1. Celebrex is one member of a class of drugs known as coxibs or COX-2 inhibitors, developed to selectively block the action of pain-causing enzymes while minimizing side effects such as gastrointestinal problems. Celebrex, a non-steroidal anti-inflammatory drug (NSAID) is the only coxib currently on the market in the US.

2. Article citation: “Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1” PNAS, Dec 1, 2009
___
Source: University of Michigan Health System press release, Dec 15, 2009




Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Optimized Curcumin Longvida® FibroSleep™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Aching for Pain Relief?

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry
Herbal Inflammation Management for Whole Body Health Herbal Inflammation Management for Whole Body Health
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler

· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map